ALM

Almonty Industries Inc. (ALM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New York, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on Almonty Industries, Inc. (Nasdaq: ALM; Frankfurt: ALI1).  The research summary below is from an issuer-sponsored report commissioned by Almonty Industries, Inc. and produced by Diamond Equity Research.

The heavy selling pressure might have exhausted for Almonty Industries Inc. (ALM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that management will host its 2026 Investor Day at 9:00 a.m. Eastern time on Monday, October 19, 2026. Almonty executive management, together with members of the Company's regional operating teams, will provide a comprehensive overview of the global tungsten market and pricing environment, followed by operational.

Almonty Industries Inc. (ALM) Presents at 20th International Investment Forum (IIF) Transcript

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company“) (NASDAQ: ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today noted that Pure Tungsten Inc. (“Pure Tungsten”) has published a clarification on its website regarding Mr. Tiger Kim's prior involvement with Almonty (the "Corrective Disclosure"), accessible at https://www.puretungsten.ca/news-1/pure-tungsten-clarification-of-tiger-kims-prior-involvement-with-almonty-industries. The Corre.

VIENNA--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced long-term results from ADlong, a Phase 3b open-label extension study evaluating the efficacy and safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis (AD). The late-breaking results of this long-term clinical study are presented at the 35th European Academy of Dermatology and Venereology (EADV) Congress, taking place in Vienna, A.

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that it has received mining facility inspection certificates for the processing plant and crushing facilities at the Sangdong Mine (“Sangdong”) in Yeongwol, Gangwon Province, South Korea. Issued September 17, 2026, the certificates authorize Almonty to commercially operate the facilities. This is the final admini.

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (Nasdaq: ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that it has entered into a long-term tungsten concentrate supply agreement with Wolfram Bergbau und Hütten AG (“WBH”), a subsidiary of the Sandvik Group, covering retreatment (“recycling”) of the Company's existing tailings stockpile at the Los Santos Mine in western Spain. The agreement is intended to create an.

DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that it has entered into a binding agreement with the Government of Rwanda (the “GOR”) under which the GOR will receive a 25% interest in Almonty Rwanda Pty Ltd (“Almonty Rwanda”) in exchange for the contribution of the Shyorongi tungsten exploration concession and a mineral processing license, with Almonty holdi.